Q1 2026 Becton Dickinson and Co Earnings Call Transcript

Feb 09, 2026 / 01:00PM GMT

Transcript 10-Q8-K

Key Points

Positve

Becton Dickinson & Co (BDX) delivered stronger than expected Q1 results, with revenues of $5.3 billion, reflecting disciplined execution and accelerated commercial initiatives.
The company achieved double-digit growth in biologic drug delivery, Purewick, advanced tissue regeneration, and pharmacy automation.
Becton Dickinson & Co (BDX) completed the combination of its life sciences business with Waters ahead of schedule, unlocking significant value for shareholders.
The company plans to deploy $2 billion towards share repurchases and $2 billion towards debt paydown, aligning with its enhanced capital allocation strategy.
Becton Dickinson & Co (BDX) is focusing on high growth platforms, with over 90% of revenues driven by recurring consumables, positioning it well for future growth.

Negative

10% of Becton Dickinson & Co (BDX)'s portfolio, including Alaris and vaccines in China, is undergoing challenging market dynamics.
Adjusted gross margin of 53.4% was down 140 basis points year-over-year, impacted by tariffs.
Adjusted operating margin of 21.2% was down 240 basis points due to tariffs and increased commercial investments.
Life sciences segment experienced a decline, impacted by US point of care headwinds and market dynamics in China.
The company faces headwinds from volume-based procurement in China and lower demand for vaccine products.

Operator

Please stand by. Your meeting is about to begin.

Hello and welcome to BD's first fiscal quarter 2026 earnings call.

At the request of BD, today's call is being recorded and will be available for replay on BD's investor relations website at investors.bd.com or by phone at 800-753-5212 for domestic calls and area code 1402-220-2673 for international calls.

For today's call, all parties have been placed in a listen-only mode until the question-and-answer session.

I will now turn the call over to Sean Bevec, senior Vice President, Investor relations. Please go ahead.

Shawn Bevec

Becton Dickinson and Co - Senior Vice President of Investor Relations

Good morning and welcome to BD's earnings call. I'm Sean Bevik, senior Vice President of Investor relations.

Thank you for joining us. This call is being made available via audio webcast at BD.com.

Earlier this morning, BD released its results for the first quarter of fiscal 2026. The press release and presentation can be accessed on the IR website at investors

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.